Table 10. Comparison of TMZ effects on hearts subjected to AHF—Lean males vs. lean females (follicular) (n = 6).
| Control | ||||||
| Parameters | Males | Females | Sig. | |||
| Heart rate (%) |
210.13 ± 127.11 | 30.21 ± 4.14 | ns | |||
| LVDevP (%) |
1259.06 ± 485.90 | 2875.81 ± 725.74 | ns | |||
| LVEDP (%) |
201.85 ±36.57 | 140.87 ± 9.40 | ns | |||
| LVESP (%) |
211.06 ± 43.49 | 149.10 ± 10.88 | ns | |||
| TMZ at CAHF | TMZ at RAHF | |||||
| Males | Females | Sig. | Males | Females | Sig. | |
| Heart rate (%) |
28.26 ± 1.48 | 27.94 ± 3.51 | ns | 29.74 ± 2.23 | 23.93 ± 2.00 | ns |
| LVDevP (%) |
2204.29 ± 355.33 | 8049.63 ± 1961.21 | *** | 6025.70 ± 654.65 | 4918.75 ± 762.73 | ns |
| LVEDP (%) |
160.23 ± 9.38 | 139.35 ± 24.49 | ns | 158.26 ± 18.72 | 137.35 ± 3.71 | ns |
| LVESP (%) |
170.36 ± 11.07 | 152.26 ± 30.49 | ns | 171.80 ± 24.07 | 145.29 ± 4.73 | ns |
Data represent the last ten minutes of the RAHF phase and is expressed as a percentage of CAHF. Significance is expressed as ***p<0.001 vs. lean males. LVDevP: left ventricular developed pressure; LVEDP: left ventricular end diastolic pressure; LVESP: left ventricular end systolic pressure; CAHF: critical acute heart failure; RAHF: recovery acute heart failure; Sig.: significance; ns: not significant.